Caricamento...
Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
Objective: Several models have been proposed for the evolution of Alzheimer’s disease (AD) biomarkers. The aim of this study was to identify changepoints in a range of biomarkers during the preclinical phase of AD. Methods: We examined nine measures based on cerebrospinal fluid (CSF), magnetic reson...
Salvato in:
| Pubblicato in: | Front Aging Neurosci |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6454004/ https://ncbi.nlm.nih.gov/pubmed/31001108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00074 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|